Embryonic Stem cell-derived hematopoietic stem cells: Challenges in development, differentiation, and immunogenicity

Current Topics in Medicinal Chemistry

Volumn 11, Issue 13, 2011, Pages 1621-1637

  Thompson, H L ^a   Manilay, J O ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Development; Embryonic stem cells; Hematopoiesis; Hematopoietic progenitor; Hematopoietic stem cell; Immunogenicity; Immunology; Tolerance

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2; TRANSFORMING GROWTH FACTOR BETA;

CD4+ CD25+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FATE; CELL MATURATION; CYTOLOGY; EMBRYONIC STEM CELL; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HISTOCOMPATIBILITY; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; NATURAL KILLER CELL; NONHUMAN; PLURIPOTENT STEM CELL; REGULATORY T LYMPHOCYTE; REVIEW; STEM CELL TRANSPLANTATION; THYMUS; UMBILICAL CORD BLOOD;

ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNE TOLERANCE;

EID: 79959933151     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/156802611796117702     Document Type: Review

References (152)

1. Bradley, J. A.; Bolton, E. M.; Pedersen, R. A. Stem cell medicine encounters the immune system. Nat. Rev. Immunol., 2002, 2, 859-871.
2. Brown, J. A.; Boussiotis, V. A. Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution. Clin. Immunol., 2008, 127, 286-297.
3. Sykes, M. Hematopoietic Cell transplantation for tolerance induction: animal models to clinical trials. Transplantation, 2009, 87, 309-316.
4. Koestenbauer, S.; Zech, N. H.; Juch, H.; Vanderzwalmen, P.; Schoonjans, L.; Dohr, G. Embryonic stem cells: Similarities and differences between human and murine embryonic stem cells. Am. J. Reprod. Immunol., 2006, 55, 169-180.
5. Burdon, T.; Smith, A.; Savatier, P. Signalling, cell cycle and pluripotency in embryonic stem cells. Trends Cell Biol., 2002, 12, 432-438.
6. Conner, D. A. Mouse embryonic stem (Es) cell culture. Curr. Protoc. Mol. Biol., 2001, Chap 23, Unit 23 23.
7. Smith, A. G.; Heath, J. K.; Donaldson, D. D.; Wong, G. G.; Moreau, J.; Stahl, M.; Rogers, D. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature, 1988, 336, 688-690.
8. Rathjen, J.; Rathjen, P. D. Mouse Es cells: Experimental exploitation of pluripotent differentiation potential. Curr. Opin. Genet. Dev., 2001, 11, 587-594.
9. Sabin, F. Preliminary note on the differentiation of angioblasts and the method by which they produce blood-vessels, blood-plasma and red blood-cells as seen in the living chick. Anatomical. Record, 1917, 13, 199-204.
10. Eilken, H. M.; Nishikawa, S.; Schroeder, T. Continuous single-cell imaging of blood generation from haemogenic endothelium. Nature, 2009, 457, 896-900.
11. Lancrin, C.; Sroczynska, P.; Stephenson, C.; Allen, T.; Kouskoff, V.; Lacaud, G. The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage. Nature, 2009, 457, 892-895.
12. Choi, K. The hemangioblast: A common progenitor of hematopoietic and endothelial cells. J. Hematother. Stem Cell Res., 2002, 11, 91-101.
13. Nishikawa, M.; Tahara, T.; Hinohara, A.; Miyajima, A.; Nakahata, T.; Shimosaka, A. Role of the microenvironment of the embryonic aorta-gonad-mesonephros region in hematopoiesis. Ann. N. Y. Acad. Sci., 2001, 938, 109-116.
14. Dzierzak, E.; Speck, N. A. Of lineage and legacy: The development of mammalian hematopoietic stem cells. Nat. Immunol., 2008, 9, 129-136.
15. Keller, G.; Lacaud, G.; Robertson, S. Development of the hematopoietic system in the mouse. Exp. Hematol., 1999, 27, 777-787.
16. Mikkola, H. K.; Orkin, S. H. The journey of developing hematopoietic stem cells. Development, 2006, 133, 3733-3744.
17. McGrath, K. E.; Palis, J. Hematopoiesis in the yolk sac: More than meets the eye. Exp. Hematol., 2005, 33, 1021-1028.
18. de Bruijn, M. F.; Speck, N. A.; Peeters, M. C.; Dzierzak, E. Definitive hematopoietic stem cells first develop within the major arterial regions of the mouse embryo. EMBO J., 2000, 19, 2465-2474.
19. Garcia-Porrero, J. A.; Godin, I. E.; Dieterlen-Lievre, F. Potential intraembryonic hemogenic sites at pre-liver stages in the mouse. Anat. Embryol (Berl), 1995, 192, 425-435.
20. Alvarez-Silva, M.; Belo-Diabangouaya, P.; Salaun, J.; Dieterlen-Lievre, F. Mouse placenta is a major hematopoietic organ. Development, 2003, 130, 5437-5444.
21. Gekas, C.; Dieterlen-Lievre, F.; Orkin, S. H.; Mikkola, H. K. The placenta is a niche for hematopoietic stem cells. Dev. Cell, 2005, 8, 365-375.
22. Mikkola, H. K.; Gekas, C.; Orkin, S. H.; Dieterlen-Lievre, F. Placenta as a site for hematopoietic stem cell development. Exp. Hematol., 2005, 33, 1048-1054.
23. Ottersbach, K.; Dzierzak, E. The murine placenta contains hematopoietic stem cells within the vascular labyrinth region. Dev. Cell, 2005, 8, 377-387.
24. Corbel, C.; Salaun, J.; Belo-Diabangouaya, P.; Dieterlen-Lievre, F. Hematopoietic potential of the pre-fusion allantois. Dev. Biol., 2007, 301, 478-488.
25. Koushik, S. V.; Wang, J.; Rogers, R.; Moskophidis, D.; Lambert, N. A.; Creazzo, T. L.; Conway, S. J. Targeted inactivation of the sodium-calcium exchanger (Ncx1) results in the lack of a heartbeat and abnormal myofibrillar organization. FASEB J., 2001, 15, 1209-1211.
26. Lux, C. T.; Yoshimoto, M.; McGrath, K.; Conway, S. J.; Palis, J.; Yoder, M. C. All primitive and definitive hematopoietic progenitor cells emerging before e10 in the mouse embryo are products of the yolk sac. Blood, 2008, 111, 3435-3438.
27. Rhodes, K. E.; Gekas, C.; Wang, Y.; Lux, C. T.; Francis, C. S.; Chan, D. N.; Conway, S.; Orkin, S. H.; Yoder, M. C.; Mikkola, H. K. The emergence of hematopoietic stem cells is initiated in the placental vasculature in the absence of circulation. Cell Stem Cell, 2008, 2, 252-263.
28. Yoshimoto, M.; Porayette, P.; Yoder, M. C. Overcoming obstacles in the search for the site of hematopoietic stem cell emergence. Cell Stem Cell, 2008, 3, 583-586.
29. North, T. E.; Goessling, W.; Peeters, M.; Li, P.; Ceol, C.; Lord, A. M.; Weber, G. J.; Harris, J.; Cutting, C. C.; Huang, P.; Dzierzak, E.; Zon, L. I. Hematopoietic stem cell development is dependent on blood flow. Cell, 2009, 137, 736-748.
30. Houssaint, E. Differentiation of the Mouse Hepatic Primordium. Ii. Extrinsic origin of the haemopoietic cell line. Cell Differ., 1981, 10, 243-252.
31. Kumaravelu, P.; Hook, L.; Morrison, A. M.; Ure, J.; Zhao, S.; Zuyev, S.; Ansell, J.; Medvinsky, A. Quantitative developmental anatomy of definitive haematopoietic stem cells/long-term repopulating units (Hsc/Rus): Role of the aorta-gonad-mesonephros (agm) region and the yolk sac in colonisation of the mouse embryonic liver. Development, 2002, 129, 4891-4899.
32. Takeuchi, M.; Sekiguchi, T.; Hara, T.; Kinoshita, T.; Miyajima, A. Cultivation of aorta-gonad-mesonephros-derived hematopoietic stem cells in the fetal liver microenvironment amplifies long-term repopulating activity and enhances engraftment to the bone marrow. Blood, 2002, 99, 1190-1196.
33. Filipovich, A. Hematopoietic cell transplantation for correction of primary immunodeficiencies. Bone Marrow Transplant., 2008, 42 (Suppl 1), S49-S52.
34. Kurtzberg, J. Update on umbilical cord blood transplantation. Curr. Opin. Pediatr., 2009, 21, 22-29.
35. Welniak, L. A.; Blazar, B. R.; Murphy, W. J. Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu. Rev. Immunol., 2007, 25, 139-170.
36. Laughlin, M. J.; Barker, J.; Bambach, B.; Koc, O. N.; Rizzieri, D. A.; Wagner, J. E.; Gerson, S. L.; Lazarus, H. M.; Cairo, M.; Stevens, C. E.; Rubinstein, P.; Kurtzberg, J. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N. Engl. J. Med., 2001, 344, 1815-1822.
37. Roy, V.; Verfaillie, C. M. Expression and function of cell adhesion molecules on fetal liver, cord blood and bone marrow hematopoietic progenitors: implications for anatomical localization and developmental stage specific regulation of hematopoiesis. Exp. Hematol., 1999, 27, 302-312.
38. Ballen, K. K.; Spitzer, T. R.; Yeap, B. Y.; McAfee, S.; Dey, B. R.; Attar, E.; Haspel, R.; Kao, G.; Liney, D.; Alyea, E.; Lee, S.; Cutler, C.; Ho, V.; Soiffer, R.; Antin, J. H. Double unrelated reducedintensity umbilical cord blood transplantation in adults. Biol. Blood Marrow Transplant, 2007, 13, 82-89.
39. Nauta, A. J.; Kruisselbrink, A. B.; Lurvink, E.; Mulder, A.; Claas, F. H.; Noort, W. A.; Willemze, R.; Fibbe, W. E. Enhanced engraftment of umbilical cord blood-derived stem cells in nod/scid mice by cotransplantation of a second unrelated cord blood unit. Exp. Hematol., 2005, 33, 1249-1256.
40. Godfrey, W. R.; Spoden, D. J.; Ge, Y. G.; Baker, S. R.; Liu, B.; Levine, B. L.; June, C. H.; Blazar, B. R.; Porter, S. B. Cord blood Cd4(+)Cd25(+)-derived t regulatory cell lines express foxp3 protein and manifest potent suppressor function. Blood, 2005, 105, 750-758.
41. Tang, Q.; Bluestone, J. A. The foxp3+ regulatory T cell: A jack of all trades, master of regulation. Nat. Immunol., 2008, 9, 239-244.
42. Levesque, J. P.; Winkler, I. G. Mobilization of hematopoietic stem cells: State of the art. Curr. Opin. Organ Transplant, 2008, 13, 53-58.
43. Mapara, M. Y.; Pelot, M.; Zhao, G.; Swenson, K.; Pearson, D.; Sykes, M. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with t celldepleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo Tolerance. Biol. Blood Marrow Transplant, 2001, 7, 646-655.
44. Spitzer, T. R.; Delmonico, F.; Tolkoff-Rubin, N.; McAfee, S.; Sackstein, R.; Saidman, S.; Colby, C.; Sykes, M.; Sachs, D. H.; Cosimi, A. B. Combined histocompatibility leukocyte antigenmatched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: The induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation, 1999, 68, 480-484.
45. Fehr, T.; Sykes, M. Clinical experience with mixed chimerism to induce transplantation tolerance. Transpl. Int., 2008, 21, 1118-1135.
46. George, T.; Yu, Y. Y.; Liu, J.; Davenport, C.; Lemieux, S.; Stoneman, E.; Mathew, P. A.; Kumar, V.; Bennett, M. Allorecognition by murine natural killer cells: lysis of t-lymphoblasts and rejection of bone-marrow grafts. Immunol. Rev., 1997, 155, 29-40.
47. Kumar, V.; George, T.; Yu, Y. Y.; Liu, J.; Bennett, M. Role of murine nk cells and their receptors in hybrid resistance. Curr. Opin. Immunol., 1997, 9, 52-56.
48. Jones, D. L.; Wagers, A. J. No place like home: Anatomy and function of the stem cell niche. Nat. Rev. Mol. Cell Biol., 2008, 9, 11-21.
49. Kiel, M. J.; Morrison, S. J. Uncertainty in the niches that maintain haematopoietic stem cells. Nat. Rev. Immunol., 2008, 8, 290-301.
50. Chidgey, A.; Dudakov, J.; Seach, N.; Boyd, R. Impact of niche aging on thymic regeneration and immune reconstitution. Semin. Immunol., 2007, 19, 331-340.
51. Murphy, K. M.; Travers, P.; Walport, M. Janeway's Immunobiology. 7th ed: Garland Science, 2007.
52. Grinnemo, K. H.; Sylven, C.; Hovatta, O.; Dellgren, G.; Corbascio, M. Immunogenicity of human embryonic stem cells. Cell Tissue Res., 2008, 331, 67-78.
53. Fabricius, D.; Bonde, S.; Zavazava, N. Induction of stable mixed chimerism by embryonic stem cells requires functional fas/fasl engagement. Transplantation, 2005, 79, 1040-1044.
54. Sykes, M. Mechanisms of Tolerance induced via mixed chimerism. Front Biosci., 2007, 12, 2922-2934.
55. Tsao, G. J.; Allen, J. A.; Logronio, K. A.; Lazzeroni, L. C.; Shizuru, J. A. Purified hematopoietic stem cell allografts reconstitute immunity superior to bone marrow. Proc. Natl. Acad. Sci. USA, 2009, 106, 3288-3293.
56. Kleinsmith, L. J.; Pierce, G. B. Jr. Multipotentiality of single embryonal carcinoma cells. Cancer Res., 1964, 24, 1544-1551.
57. Martin, G. R.; Evans, M. J. Differentiation of clonal lines of teratocarcinoma cells: formation of embryoid bodies in vitro. Proc. Natl. Acad. Sci. USA, 1975, 72, 1441-1445.
58. Evans, M. J.; Kaufman, M. H. Establishment in culture of pluripotential cells from mouse embryos. Nature, 1981, 292, 154-156.
59. Martin, G. R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA, 1981, 78, 7634-7638.
60. Thomas, K. R.; Capecchi, M. R. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell, 1987, 51, 503-512.
61. Thomson, J. A.; Itskovitz-Eldor, J.; Shapiro, S. S.; Waknitz, M. A.; Swiergiel, J. J.; Marshall, V. S.; Jones, J. M. Embryonic stem cell lines derived from human blastocysts. Science, 1998, 282, 1145-1147.
62. Amit, M.; Carpenter, M. K.; Inokuma, M. S.; Chiu, C. P.; Harris, C. P.; Waknitz, M. A.; Itskovitz-Eldor, J.; Thomson, J. A. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev. Biol., 2000, 227, 271-278.
63. Conley, B. J.; Denham, M.; Gulluyan, L.; Olsson, F.; Cole, T. J.; Mollard, R. Mouse embryonic stem cell derivation, and mouse and human embryonic stem cell culture and differentiation as embryoid bodies. Curr. Protoc. Cell Biol., 2005, Chap. 23, Unit 23 22.
64. Keller, G.; Kennedy, M.; Papayannopoulou, T.; Wiles, M. V. Hematopoietic commitment during embryonic stem cell differentiation in culture. Mol. Cell Biol., 1993, 13, 473-486.
65. Wiles, M. V.; Keller, G. Multiple hematopoietic lineages develop from embryonic stem (Es) cells in culture. Development, 1991, 111, 259-267.
66. Chen, U. Differentiation of mouse embryonic stem cells to lymphohematopoietic lineages in vitro. Dev. Immunol., 1992, 2, 29-50.
67. Chen, U.; Kosco, M.; Staerz, U. Establishment and characterization of lymphoid and myeloid mixed-cell populations from mouse late embryoid bodies, "embryonic-stem-cell fetuses". Proc. Natl. Acad. Sci. USA, 1992, 89, 2541-2545.
68. Potocnik, A. J.; Kohler, H.; Eichmann, K. Hemato-lymphoid in vivo reconstitution potential of subpopulations derived from in vitro differentiated embryonic stem cells. Proc. Natl. Acad. Sci. USA, 1997, 94, 10295-10300.
69. Gutierrez-Ramos, J. C.; Palacios, R. In Vitro Differentiation of embryonic stem cells into lymphocyte precursors able to generate T and B lymphocytes in Vivo. Proc. Natl. Acad. Sci. USA, 1992, 89, 9171-9175.
70. Nakano, T.; Kodama, H.; Honjo, T. Generation of lymphohematopoietic cells from embryonic stem cells in culture. Science, 1994, 265, 1098-1101.
71. Palacios, R.; Golunski, E.; Samaridis, J. In Vitro Generation of Hematopoietic Stem Cells from an Embryonic Stem Cell Line. Proc. Natl. Acad. Sci. USA, 1995, 92, 7530-7534.
72. Schmitt, T. M.; de Pooter, R. F.; Gronski, M. A.; Cho, S. K.; Ohashi, P. S.; Zuniga-Pflucker, J. C. Induction of T cell development and establishment of T cell competence from embryonic stem cells differentiated in Vitro. Nat. Immunol., 2004, 5, 410-417.
73. McKinney-Freeman, S. L.; Naveiras, O.; Daley, G. Q. Isolation of hematopoietic stem cells from mouse embryonic stem cells. Curr. Protoc. Stem Cell Biol., 2008, Chap. 1, Unit 1F 3.
74. Burt, R. K.; Verda, L.; Kim, D. A.; Oyama, Y.; Luo, K.; Link, C. Embryonic stem cells as an alternate marrow donor source: engraftment without graft-versus-host disease. J. Exp. Med., 2004, 199, 895-904.
75. Verda, L.; Kim, D. A.; Ikehara, S.; Statkute, L.; Bronesky, D.; Petrenko, Y.; Oyama, Y.; He, X.; Link, C.; Vahanian, N. N.; Burt, R. K. Hematopoietic mixed chimerism derived from allogeneic embryonic stem cells prevents autoimmune diabetes mellitus in nod mice. Stem Cells, 2008, 26, 381-386.
76. Antonchuk, J.; Sauvageau, G.; Humphries, R. K. Hoxb4 overexpression mediates very rapid stem cell regeneration and competitive hematopoietic repopulation. Exp. Hematol., 2001, 29, 1125-1134.
77. Helgason, C. D.; Sauvageau, G.; Lawrence, H. J.; Largman, C.; Humphries, R. K. Overexpression of Hoxb4 enhances the hematopoietic potential of embryonic stem cells differentiated in vitro. Blood, 1996, 87, 2740-2749.
78. Kyba, M.; Perlingeiro, R. C.; Daley, G. Q. Hoxb4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell, 2002, 109, 29-37.
79. Pilat, S.; Carotta, S.; Schiedlmeier, B.; Kamino, K.; Mairhofer, A.; Will, E.; Modlich, U.; Steinlein, P.; Ostertag, W.; Baum, C.; Beug, H.; Klump, H. Hoxb4 enforces equivalent fates of es-cell-derived and adult hematopoietic cells. Proc. Natl. Acad. Sci. USA, 2005, 102, 12101-12106.
80. Wang, Y.; Yates, F.; Naveiras, O.; Ernst, P.; Daley, G. Q. Embryonic stem cell-derived hematopoietic stem cells. Proc. Natl. Acad. Sci. USA, 2005, 102, 19081-19086.
81. Chan, K. M.; Bonde, S.; Klump, H.; Zavazava, N. Hematopoiesis and immunity of hoxb4-transduced embryonic stem cell-derived hematopoietic progenitor cells. Blood, 2008, 111, 2953-2961.
82. Dahl, L.; Richter, K.; Hagglund, A. C.; Carlsson, L. Lhx2 expression promotes self-renewal of a distinct multipotential hematopoietic progenitor cell in embryonic stem cell-derived embryoid bodies. PLoS One, 2008, 3, e2025.
83. Kiel, M. J.; Yilmaz, O. H.; Iwashita, T.; Yilmaz, O. H.; Terhorst, C.; Morrison, S. J. Slam family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell, 2005, 121, 1109-1121.
84. Kim, I.; He, S.; Yilmaz, O. H.; Kiel, M. J.; Morrison, S. J. Enhanced purification of fetal liver hematopoietic stem cells using slam family receptors. Blood, 2006, 108, 737-744.
85. Ferkowicz, M. J.; Starr, M.; Xie, X.; Li, W.; Johnson, S. A.; Shelley, W. C.; Morrison, P. R.; Yoder, M. C. Cd41 expression defines the onset of primitive and definitive hematopoiesis in the murine embryo. Development, 2003, 130, 4393-4403.
86. Mikkola, H. K.; Fujiwara, Y.; Schlaeger, T. M.; Traver, D.; Orkin, S. H. Expression of Cd41 marks the initiation of definitive hematopoiesis in the mouse embryo. Blood, 2003, 101, 508-516.
87. Kabrun, N.; Buhring, H. J.; Choi, K.; Ullrich, A.; Risau, W.; Keller, G. Flk-1 expression defines a population of early embryonic hematopoietic precursors. Development, 1997, 124, 2039-2048.
88. Ling, V.; Neben, S. In vitro differentiation of embryonic stem cells: immunophenotypic analysis of cultured embryoid bodies. J. Cell Physiol., 1997, 171, 104-115.
89. Yamane, T.; Hosen, N.; Yamazaki, H.; Weissman, I. L. Expression of Aa4.1 marks lymphohematopoietic progenitors in early mouse development. Proc. Natl. Acad. Sci. USA, 2009, 106, 8953-8958.
90. Matsumoto, K.; Isagawa, T.; Nishimura, T.; Ogaeri, T.; Eto, K.; Miyazaki, S.; Miyazaki, J.; Aburatani, H.; Nakauchi, H.; Ema, H. Stepwise development of hematopoietic stem cells from embryonic stem cells. PLoS One, 2009, 4, e4820.
91. McKinney-Freeman, S. L.; Naveiras, O.; Yates, F.; Loewer, S.; Philitas, M.; Curran, M.; Park, P. J.; Daley, G. Q. Surface antigen phenotypes of hematopoietic stem cells from embryos and murine embryonic stem cells. Blood, 2009, 114, 268-278.
92. Drukker, M.; Katchman, H.; Katz, G.; Even-Tov Friedman, S.; Shezen, E.; Hornstein, E.; Mandelboim, O.; Reisner, Y.; Benvenisty, N. Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells, 2006, 24, 221-229.
93. Bonde, S.; Zavazava, N. Immunogenicity and engraftment of mouse embryonic stem cells in allogeneic recipients. Stem Cells, 2006, 24, 2192-2201.
94. Drukker, M.; Katz, G.; Urbach, A.; Schuldiner, M.; Markel, G.; Itskovitz-Eldor, J.; Reubinoff, B.; Mandelboim, O.; Benvenisty, N. Characterization of the expression of mhc proteins in human embryonic stem cells. Proc. Natl. Acad. Sci. USA, 2002, 99, 9864-9869.
95. Swijnenburg, R. J.; Schrepfer, S.; Cao, F.; Pearl, J. I.; Xie, X.; Connolly, A. J.; Robbins, R. C.; Wu, J. C. In vivo imaging of embryonic stem cells reveals patterns of survival and immune rejection following transplantation. Stem Cells Dev., 2008, 17, 1023-1029.
96. Swijnenburg, R. J.; Schrepfer, S.; Govaert, J. A.; Cao, F.; Ransohoff, K.; Sheikh, A. Y.; Haddad, M.; Connolly, A. J.; Davis, M. M.; Robbins, R. C.; Wu, J. C. Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Proc. Natl. Acad. Sci. USA, 2008, 105, 12991-12996.
97. Seliger, B.; Ritz, U.; Ferrone, S. Molecular mechanisms of Hla class i antigen abnormalities following viral infection and transformation. Int. J. Cancer, 2006, 118, 129-138.
98. Frenzel, L. P.; Abdullah, Z.; Kriegeskorte, A. K.; Dieterich, R.; Lange, N.; Busch, D. H.; Kronke, M.; Utermohlen, O.; Hescheler, J.; Saric, T. Role of natural-killer group 2 member D ligands and intercellular adhesion molecule 1 in natural killer cell-mediated lysis of murine embryonic stem cells and embryonic stem cellderived cardiomyocytes. Stem Cells, 2009, 27, 307-316.
99. Joncker, N. T.; Raulet, D. H. Regulation of Nk cell responsiveness to achieve self-tolerance and maximal responses to diseased target cells. Immunol. Rev., 2008, 224, 85-97.
100. Zhao, Y.; Ohdan, H.; Manilay, J. O.; Sykes, M. Nk cell tolerance in mixed allogeneic chimeras. J. Immunol., 2003, 170, 5398-5405.
101. Manilay, J. O.; Waneck, G. L.; Sykes, M. Levels of Ly-49 receptor expression are determined by the frequency of interactions with mhc ligands: evidence against receptor calibration to A "Useful" level. J. Immunol., 1999, 163, 2628-2633.
102. Manilay, J. O.; Waneck, G. L.; Sykes, M. Altered expression of Ly-49 receptors on Nk cells developing in mixed allogeneic bone marrow chimeras. Int. Immunol., 1998, 10, 1943-1955.
103. Utermohlen, O.; Baschuk, N.; Abdullah, Z.; Engelmann, A.; Siebolts, U.; Wickenhauser, C.; Stocking, C.; Kronke, M. Immunologic hurdles of therapeutic stem cell transplantation. Biol. Chem., 2009, 390, 977-983.
104. Abdullah, Z.; Saric, T.; Kashkar, H.; Baschuk, N.; Yazdanpanah, B.; Fleischmann, B. K.; Hescheler, J.; Kronke, M.; Utermohlen, O. Serpin-6 expression protects embryonic stem cells from lysis by antigen-specific Ctl. J. Immunol., 2007, 178, 3390-3399.
105. del Rio, M. L.; Buhler, L.; Gibbons, C.; Tian, J.; Rodriguez-Barbosa, J. I. Pd-1/Pd-L1, Pd-1/Pd-L2, and other Co-inhibitory signaling pathways in transplantation. Transpl. Int., 2008, 21, 1015-1028.
106. Anderson, M. S.; Bluestone, J. A. The nod mouse: A model of immune dysregulation. Annu. Rev. Immunol., 2005, 23, 447-485.
107. Bour-Jordan, H.; Salomon, B. L.; Thompson, H. L.; Szot, G. L.; Bernhard, M. R.; Bluestone, J. A. Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells. J. Clin. Invest., 2004, 114, 979-987.
108. Fife, B. T.; Pauken, K. E.; Eagar, T. N.; Obu, T.; Wu, J.; Tang, Q.; Azuma, M.; Krummel, M. F.; Bluestone, J. A. Interactions between Pd-1 and Pd-L1 promote tolerance by blocking the Tcr-induced stop signal. Nat. Immunol., 2009, 10, 1185-1192.
109. Keir, M. E.; Butte, M. J.; Freeman, G. J.; Sharpe, A. H. Pd-1 and Its ligands in tolerance and immunity. Annu. Rev. Immunol., 2008, 26, 677-704.
110. Sharpe, A. H.; Wherry, E. J.; Ahmed, R.; Freeman, G. J. The function of programmed cell death 1 and its ligands in regulating autoimmunity and Infection. Nat. Immunol., 2007, 8, 239-245.
111. Law, C. L.; Grewal, I. S. Therapeutic interventions targeting Cd40l (Cd154) and Cd40: the opportunities and challenges. Adv. Exp. Med. Biol., 2009, 647, 8-36.
112. Carlyle, J. R.; Mesci, A.; Fine, J. H.; Chen, P.; Belanger, S.; Tai, L. H.; Makrigiannis, A. P. Evolution of the Ly49 and Nkrp1 recognition systems. Semin. Immunol., 2008, 20, 321-330.
113. Lanier, L. L. Up on the tightrope: Natural killer cell activation and inhibition. Nat. Immunol., 2008, 9, 495-502.
114. Colmenero, P.; Zhang, A. L.; Qian, T.; Lu, L.; Cantor, H.; Soderstrom, K.; Engleman, E. G. Qa-1(B)-dependent modulation of dendritic cell and Nk cell cross-talk in vivo. J. Immunol., 2007, 179, 4608-4615.
115. Kim, C. Y.; Masli, S.; Streilein, J. W. Qa-1, a Nonclassical Mhc molecule with immunomodulatory functions, is ubiquitously expressed in the immune-privileged anterior chamber of the eye. Ocul. Immunol. Inflamm., 2005, 13, 271-277.
116. Rotzschke, O.; Falk, K.; Stevanovic, S.; Grahovac, B.; Soloski, M. J.; Jung, G.; Rammensee, H. G. Qa-2 molecules are peptide receptors of higher stringency than ordinary class i molecules. Nature, 1993, 361, 642-644.
117. Jensen, P. E.; Sullivan, B. A.; Reed-Loisel, L. M.; Weber, D. A. Qa-1, a nonclassical class i histocompatibility molecule with roles in innate and adaptive immunity. Immunol. Res., 2004, 29, 81-92.
118. Rodgers, J. R.; Cook, R. G. Mhc class Ib molecules bridge innate and acquired immunity. Nat. Rev. Immunol., 2005, 5, 459-471.
119. Jurisicova, A.; Casper, R. F.; MacLusky, N. J.; Mills, G. B.; Librach, C. L. Hla-G expression during preimplantation human embryo development. Proc. Natl. Acad. Sci. USA, 1996, 93, 161-165.
120. Warner, C. M.; Gollnick, S. O.; Flaherty, L.; Goldbard, S. B. Analysis of Qa-2 antigen expression by preimplantation mouse embryos: possible relationship to the preimplantation-embryodevelopment (Ped) gene product. Biol. Reprod., 1987, 36, 611-616.
121. Cerwenka, A.; Baron, J. L.; Lanier, L. L. Ectopic Expression of retinoic acid early inducible-1 gene (Rae-1) permits natural killer cell-mediated rejection of a Mhc class I-bearing tumor in vivo. Proc. Natl. Acad. Sci. USA, 2001, 98, 11521-11526.
122. Tabayoyong, W. B.; Salas, J. G.; Bonde, S.; Zavazava, N. Hoxb4-transduced embryonic stem cell-derived lin(-)C-Kit(+) and lin(-)Sca-1(+) hematopoietic progenitors express H60 and are targeted by Nk cells. J. Immunol., 2009, 183, 5449-5457.
123. Vaidya, S. V.; Stepp, S. E.; McNerney, M. E.; Lee, J. K.; Bennett, M.; Lee, K. M.; Stewart, C. L.; Kumar, V.; Mathew, P. A. Targeted Disruption of the 2b4 gene in mice reveals an in vivo role of 2b4 (Cd244) in the rejection of b16 melanoma cells. J. Immunol., 2005, 174, 800-807.
124. Preynat-Seauve, O.; de Rham, C.; Tirefort, D.; Ferrari-Lacraz, S.; Krause, K. H.; Villard, J. Neural progenitors derived from human embryonic stem cells are targeted by allogeneic T and natural killer cells. J. Cell Mol. Med., 2009.
125. Muul, L. M.; Silvin, C.; James, S. P.; Candotti, F. Measurement of proliferative responses of cultured lymphocytes. Curr. Protoc. Immunol., 2008, Chap. 7, Unit 7 10 11-17 10 24.
126. Wonderlich, J.; Shearer, G.; Livingstone, A.; Brooks, A. Induction and measurement of cytotoxic T lymphocyte activity. Curr. Protoc. Immunol., 2006, Chapter 3, Unit 3 11.
127. Gerdes, J.; Schwab, U.; Lemke, H.; Stein, H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int. J. Cancer, 1983, 31, 13-20.
128. Malyguine, A.; Derby, E.; Brooks, A.; Reddy, V.; Baseler, M.; Sayers, T. Study of diverse mechanisms of cell-mediated cytotoxicity in gene-targeted mice using flow cytometric cytotoxicity assay. Immunol. Lett., 2002, 83, 55-59.
129. Pandiyan, P.; Zheng, L.; Ishihara, S.; Reed, J.; Lenardo, M. J. Cd4+Cd25+Foxp3+ regulatory T cells induce cytokine deprivationmediated apoptosis of effector Cd4+ T cells. Nat. Immunol., 2007, 8, 1353-1362.
130. Dorshkind, K.; Pollack, S. B.; Bosma, M. J.; Phillips, R. A. Natural killer (Nk) cells are present in mice with severe combined immunodeficiency (Scid). J. Immunol., 1985, 134, 3798-3801.
131. Shinkai, Y.; Rathbun, G.; Lam, K. P.; Oltz, E. M.; Stewart, V.; Mendelsohn, M.; Charron, J.; Datta, M.; Young, F.; Stall, A. M. Rag-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell, 1992, 68, 855-867.
132. Cao, X.; Shores, E. W.; Hu-Li, J.; Anver, M. R.; Kelsall, B. L.; Russell, S. M.; Drago, J.; Noguchi, M.; Grinberg, A.; Bloom, E. T. Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity, 1995, 2, 223-238.
133. Bonde, S.; Chan, K. M.; Zavazava, N. Es-cell derived hematopoietic cells induce transplantation tolerance. PLoS One, 2008, 3, e3212.
134. West, L. J.; Tao, K. Acceptance of third-party cardiac but not skin allografts induced by neonatal exposure to semi-allogeneic lymphohematopoietic cells. Am. J. Transplant., 2002, 2, 733-744.
135. Youssef, A. R.; Otley, C.; Mathieson, P. W.; Smith, R. M. Effector mechanisms in murine allograft rejection: comparison of skin and heart grafts in fully allogeneic and minor histocompatibility antigen-mismatched strain combinations. Transpl. Int., 2002, 15, 302-309.
136. Chidgey, A. P.; Layton, D.; Trounson, A.; Boyd, R. L. Tolerance strategies for stem-cell-based therapies. Nature, 2008, 453, 330-337.
137. Zhang, J.; Niu, C.; Ye, L.; Huang, H.; He, X.; Tong, W. G.; Ross, J.; Haug, J.; Johnson, T.; Feng, J. Q.; Harris, S.; Wiedemann, L. M.; Mishina, Y.; Li, L. Identification of the haematopoietic stem cell niche and control of the niche size. Nature, 2003, 425, 836-841.
138. Baldwin, W. M.; Ota, H.; Rodriguez, E. R. Complement in transplant rejection: diagnostic and mechanistic considerations. Springer Semin. Immunopathol., 2003, 25, 181-197.
139. Thurman, J. M.; Holers, V. M. The central role of the alternative complement pathway in human disease. J. Immunol., 2006, 176, 1305-1310.
140. Koch, C. A.; Jordan, C. E.; Platt, J. L. Complement-dependent control of teratoma formation by embryonic stem cells. J. Immunol., 2006, 177, 4803-4809.
141. van den Berg, T. K.; van der Schoot, C. E. Innate immune 'self' recognition: A role for Cd47-sirpalpha interactions in hematopoietic stem cell transplantation. Trends Immunol., 2008, 29, 203-206.
142. Jaiswal, S.; Jamieson, C. H.; Pang, W. W.; Park, C. Y.; Chao, M. P.; Majeti, R.; Traver, D.; van Rooijen, N.; Weissman, I. L. Cd47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell, 2009, 138, 271-285.
143. Ishikawa-Sekigami, T.; Kaneko, Y.; Saito, Y.; Murata, Y.; Okazawa, H.; Ohnishi, H.; Oldenborg, P. A.; Nojima, Y.; Matozaki, T. Enhanced Phagocytosis of Cd47-deficient red blood cells by splenic macrophages requires shps-1. Biochem. Biophys. Res. Commun., 2006, 343, 1197-1200.
144. Oldenborg, P. A. Role of Cd47 in erythroid cells and in autoimmunity. Leuk Lymphoma, 2004, 45, 1319-1327.
145. Takenaka, K.; Prasolava, T. K.; Wang, J. C.; Mortin-Toth, S. M.; Khalouei, S.; Gan, O. I.; Dick, J. E.; Danska, J. S. Polymorphism in sirpa modulates engraftment of human hematopoietic stem cells. Nat. Immunol., 2007, 8, 1313-1323.
146. Piccio, L.; Vermi, W.; Boles, K. S.; Fuchs, A.; Strader, C. A.; Facchetti, F.; Cella, M.; Colonna, M. Adhesion of human T cells to antigen-presenting cells through sirpbeta2-Cd47 interaction costimulates T-cell proliferation. Blood, 2005, 105, 2421-2427.
147. Gui, J.; Zhu, X.; Dohkan, J.; Cheng, L.; Barnes, P. F.; Su, D. M. The aged thymus shows normal recruitment of lymphohematopoietic progenitors but has defects in thymic epithelial cells. Int. Immunol., 2007, 19, 1201-1211.
148. Sutherland, J. S.; Goldberg, G. L.; Hammett, M. V.; Uldrich, A. P.; Berzins, S. P.; Heng, T. S.; Blazar, B. R.; Millar, J. L.; Malin, M. A.; Chidgey, A. P.; Boyd, R. L. Activation of thymic regeneration in mice and humans following androgen blockade. J. Immunol., 2005, 175, 2741-2753.
149. McLelland B, Gravano D, Castillo J, Montoy S and Manilay JO. (2011). Enhanced Isolation of Adult Thymic Epithelial Cell Subsets for Multiparameter Flow Cytometry and Gene Expression Analysis. J. Immunol. Methods, Epub 2011 Feb 23. PMID: 21354161
150. Robertson, N. J.; Brook, F. A.; Gardner, R. L.; Cobbold, S. P.; Waldmann, H.; Fairchild, P. J. Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance. Proc. Natl. Acad. Sci. USA, 2007, 104, 20920-20925.
151. Yamanaka, S. A fresh look at ips cells. Cell, 2009, 137, 13-17.
152. Niwa, A.; Umeda, K.; Chang, H.; Saito, M.; Okita, K.; Takahashi, K.; Nakagawa, M.; Yamanaka, S.; Nakahata, T.; Heike, T. Orderly hematopoietic development of induced pluripotent stem cells via Flk-1(+) hemoangiogenic progenitors. J. Cell Physiol., 2009, 221, 367-377.